A Systematic Review on PETTICOAT and STABILISE Techniques for the Management of Complicated Acute Type B Aortic

Petroula Nana1, George Kouvelos1, Christian-Alexander Behrendt2

  • 1Vascular Surgery Department, Larissa University Hospital, Faculty of Medicine, University of Thessaly, 41110 Larissa, Greece.

Insights

The Provisional Extension To Induce Complete Attachment (PETTICOAT) and stent-assisted balloon-induced intimal disruption and relamination (STABILISE) techniques show high technical success and low 30-day mortality for acute complicated type B aortic dissection. Mid-term mortality was 6%, indicating a need for further research.

Area of Science:

  • Cardiovascular Surgery
  • Endovascular Interventions
  • Aortic Disease Management

Background:

  • Acute complicated type B aortic dissection (acTBAD) management often requires extended downstream endovascular repair.
  • Techniques like Provisional Extension To Induce Complete Attachment (PETTICOAT) and stent-assisted balloon-induced intimal disruption and relamination (STABILISE) are used for distal TEVAR extension.
  • These methods involve bare metal stents, lamina disruption, and balloon inflation.

Purpose of the Study:

  • To systematically review the technical success, 30-day mortality, and follow-up mortality in acTBAD patients treated with PETTICOAT or STABILISE.
  • To evaluate the efficacy and safety of these advanced endovascular techniques.

Main Methods:

  • A systematic review adhering to PRISMA 2020 guidelines.
  • Literature search of MEDLINE, EMBASE, and CENTRAL databases up to August 30, 2022.
  • Inclusion of randomized controlled trials and observational studies (2000-2022) with >=5 patients, assessing technical success, 30-day, and follow-up mortality.

Main Results:

  • Thirteen studies (418 patients) were included; 83% received PETTICOAT, 17% STABILISE.
  • Technical success rates were high: 97-100% (PETTICOAT 99%, STABILISE 100%).
  • 30-day mortality was 3.7% overall (PETTICOAT 4.4%, STABILISE 1.4%). Follow-up mortality was 5.7% (PETTICOAT 7.0%, STABILISE 0%).

Conclusions:

  • Both PETTICOAT and STABILISE techniques demonstrate high technical success and low perioperative mortality (<4%) in acTBAD.
  • Mid-term mortality is approximately 6%, with STABILISE showing 0% mortality in this review.
  • Further prospective studies with larger cohorts and longer follow-up are necessary due to study heterogeneity.
Abstract